|
JAMA Cardiology |
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials - A Call to Action From the Heart Failure Collaboratory |
1 |
Yes |
3/23/2025 |
|
JAMA Network Open |
Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021 |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore |
1 |
Yes |
3/18/2025 |
|
JAMA Pediatrics |
Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan - Results of the 26th Nationwide Survey, 2019 to 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA Pediatrics |
Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic |
1 |
Yes |
1/26/2025 |
|
JAMA |
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines |
1 |
Yes |
10/26/2025 |
|
JAMA Cardiology |
Incidental Complication From a Left Atrial Appendage Device |
1 |
Yes |
7/3/2027 |
|
JAMA Internal Medicine |
Incorrect Electrocardiogram Lead Placement in ST-Segment Elevation Myocardial Infarction |
1 |
Yes |
8/14/2026 |
|
American Medical Association |
Increasing Annual Prescription Renewal for Patients on Chronic Medications |
5 |
Yes |
12/15/2025 |
|
Massachusetts Medical Society |
Increasing HPV Vaccination Uptake in Massachusetts |
1 |
No |
7/16/2027 |
|
American Medical Association |
Indigenous Approaches to Infection Prevention and Control |
0.5 |
Yes |
9/22/2025 |
|
JAMA Dermatology |
Indurated Plaque With Ulceration on the Dorsum of the Left Hand |
1 |
Yes |
11/9/2025 |
|
American Medical Association |
Information Blocking Regulations: What to Know and How to Comply |
0.75 |
Yes |
3/19/2027 |
|
AMA Journal of Ethics |
Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm |
1 |
Yes |
11/1/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement |
1 |
Yes |
7/11/2027 |
|
American Medical Association |
Injection Safety for Infection Prevention in a Dialysis Setting |
0.75 |
Yes |
2/7/2026 |
|
JAMA Internal Medicine |
Inpatient Management of Type 2 Diabetes |
1 |
Yes |
3/21/2025 |
|
JAMA |
Instrumental Variables and Heterogeneous Treatment Effects |
1 |
Yes |
3/22/2025 |
